Last reviewed · How we verify
Deferasirox, Vitamin D and Azacitidine
Deferasirox, Vitamin D and Azacitidine is a Small molecule drug developed by Groupe Francophone des Myelodysplasies. It is currently in Phase 1 development. Also known as: Exjade, VitaminD, Vidaza.
At a glance
| Generic name | Deferasirox, Vitamin D and Azacitidine |
|---|---|
| Also known as | Exjade, VitaminD, Vidaza |
| Sponsor | Groupe Francophone des Myelodysplasies |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Deferasirox, Vitamin D and Azacitidine CI brief — competitive landscape report
- Deferasirox, Vitamin D and Azacitidine updates RSS · CI watch RSS
- Groupe Francophone des Myelodysplasies portfolio CI
Frequently asked questions about Deferasirox, Vitamin D and Azacitidine
What is Deferasirox, Vitamin D and Azacitidine?
Deferasirox, Vitamin D and Azacitidine is a Small molecule drug developed by Groupe Francophone des Myelodysplasies.
Who makes Deferasirox, Vitamin D and Azacitidine?
Deferasirox, Vitamin D and Azacitidine is developed by Groupe Francophone des Myelodysplasies (see full Groupe Francophone des Myelodysplasies pipeline at /company/groupe-francophone-des-myelodysplasies).
Is Deferasirox, Vitamin D and Azacitidine also known as anything else?
Deferasirox, Vitamin D and Azacitidine is also known as Exjade, VitaminD, Vidaza.
What development phase is Deferasirox, Vitamin D and Azacitidine in?
Deferasirox, Vitamin D and Azacitidine is in Phase 1.
Related
- Manufacturer: Groupe Francophone des Myelodysplasies — full pipeline
- Also known as: Exjade, VitaminD, Vidaza
- Compare: Deferasirox, Vitamin D and Azacitidine vs similar drugs
- Pricing: Deferasirox, Vitamin D and Azacitidine cost, discount & access